FORT WASHINGTON, Pennsylvania, July 20, 2011 /PRNewswire/ --
ReSearch Pharmaceutical Services, Inc. (RPS), a next generation CRO that provides comprehensive global Phase II-IV clinical development solutions to the biopharmaceutical and medical device industries, today announced the following key additions to its Operational and Senior Management team.
- John K. Davis, II, as Chief Information Officer and Executive Vice President, Clinical Systems
- Martine Dehlinger-Kremer, Ph.D. as Vice President, Global Regulatory Affairs
- Debra Marshall as Vice President, Clinical Programs and Global Site Management
- Lexy Kelley, MD as Medical Director, Immunology Development Services
- Peggy Doran as Executive Director, R&D Business Operations Management
"RPS is extremely pleased to add such a talented and experienced team to our organization," said Harris Koffer, Pharm.D., President and COO. "These additions will further strengthen our position as an innovator and leading provider of Embedded and Full-Service clinical development solutions in support of our clients expanding global product development needs."
John K. Davis, II brings more than 30 years of experience as an accomplished CIO and operations executive. He previously served as Senior Vice President and Chief Information Officer at the American Board of Internal Medicine (ABIM) and Executive Vice President and CIO at Omnicare Clinical Research, where he led the globalization of the Clinical Data Management, Biostatistics, Information Technology, Clinical Writing, and Training functions.
Martine Dehlinger-Kremer, Ph.D. has over 24 years of experience in the pharmaceutical industry with extensive expertise in global Regulatory Affairs. She most recently served as the Vice President of Global Regulatory Affairs and Global Medical Affairs at Theorem Clinical Research (previously Omnicare Clinical Research).
Debra Marshall has over 30 years of healthcare and pharmaceutical industry management experience and most recent served as Assistant Vice President, US Global Site Management for Pfizer (formerly Wyeth), where she was instrumental in building a high performing Site Management Organization and implementing enhanced Site Management strategies.
Lexy Kelley, MD brings strong experience in the design, implementation and medical oversight of clinical development programs for the treatment of Lupus as well as clinical research experience in hematology, infectious diseases, rheumatology and allergy. Prior to joining RPS, she served as an Associate Medical Director at UCB Pharma.
Marguerite (Peggy) Doran has over 25 years of pharmaceutical industry experience, including 18 years of experience in contract negotiation and management, implementation of sourcing strategies, contract optimization and process improvements as well as vendor relationship management and governance programs.
"Because of our unique business model, RPS has achieved impressive growth rates that far exceed those in the late stage CRO marketplace," said Daniel M. Perlman, Chairman and CEO. "The new additions to our organization are a key component of our continued focus on growth and innovation in support of the global biopharmaceutical and medical device industries."
RPS provides comprehensive global Phase II-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries. By combining our highly experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions. These solutions range from globally Embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project teams providing innovative, seamless, cost-effective and high quality services.
With more than 3,000 employees, RPS operates in 45 countries across the globe.
SOURCE ReSearch Pharmaceutical Services, Inc.